Immune checkpoint inhibitor-based combinations have become the preferred first-line therapy for patients with metastatic clear cell renal cell carcinoma, but more than a third of eligible patients do ...

XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease , is pleased ...

Largest multi-center prospective Investigational Device Exemption (IDE) study for multi-port robotic-assisted urologic ...

Slideshows ...

Birthmarks are considered as indications for reincarnation Researcher Ian Stevenson found numerous examples of birthmark cases In one such case as documented by Stevenson an Indian boy was born withou ...